Sally Church· @MaverickNY · X·· 18 小时前评分45
正文 · 原文
Red and green flag analysis of Tango Therapeutics' PRMT5 inhibitor in combination with $RVMD daraxonrasib in pancreatic cancer at #ESMO26
Elicio's vaccine didn't pan out after encouraging Ph1 data – will this go the same way?
https://tinyurl.com/2hbaj5zy
306 浏览 · 5 赞 · 0 转发 · 0 回复
会议摘要
LBA82按 Proffered paper 1: Gastrointestinal tumour, upper digestive 对上
Daraxonrasib, a RAS(ON) multi-selective inhibitor vs chemotherapy in previously treated metastatic pancreatic adenocarcinoma (mPDAC): Additional subgroup analyses from the ph3 RASolute 302 study
https://esmocongress.esmo.org来源：Sally Church · x.com